A 3242
Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed General Assembly
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill requires New Jersey health insurance plans to cover the costs of continuous glucose monitoring (CGM) systems for individuals diagnosed with glycogen storage disease. These systems are prescribed by healthcare professionals to help manage the condition. The bill ensures that patients with this rare genetic disorder have access to the necessary technology for effective treatment. The effective date for coverage changes has been adjusted to January 1, 2027.
Sponsors
Official sponsors from legislative records.
Primary sponsors
Cosponsor
Cody Miller
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.